Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%
MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company today announced that it will present at the 2026 Annual Smallcap Discoveries Conference, being held at the JW Marriott Parq in Vancouver, British Columbia, Canada on September 28 and 29, 2026.
Brent Ashton, Covalon’s Chief Executive Officer, will present on Monday, September 28, 2026, at 10:00 a.m. PT (1:00 p.m. ET) and will also participate in one-on-one meetings with investors during the conference.
The presentation follows Covalon’s fiscal 2026 third quarter results, reported on August 27, 2026, in which the Company delivered the strongest quarter in its recent history:
A welcome email is on its way. If you don't see it, please check your junk folder.
“Covalon is exactly the kind of company this conference was built for,” said Brent Ashton, Chief Executive Officer of Covalon. “The Smallcap Discoveries community is on the hunt for profitable, growing companies with strong balance sheets that the broader market has not found yet. I am looking forward to walking investors through how we got here and what we are building.”
Investors interested in attending the presentation or arranging a one-on-one meeting with Covalon during the conference can find registration and agenda details at https://smallcapdiscoveries.com/annual-smallcap-discoveries-conference-2026 or contact Smallcap Discoveries directly.
Those interested in learning about Covalon’s solutions may visit www.covalon.com or follow Covalon on LinkedIn , Facebook , Instagram , or X .
Covalon is a leading MedTech company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. Our expertise spans advanced wound care, vascular access, and surgical consumables, with a strong focus on enhancing healing, reducing healthcare-associated infections (HAIs), and protecting skin integrity. Our solutions are designed for patients and made for care providers. The Company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX Market (CVALF). To learn more about Covalon, visit our website at www.covalon.com .
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.